IgG1 Ab1(Abound bio/Saudivax)

N/A

Report date: 2025/01/26 18:42:00

Base Information

Drug NameIgG1 Ab1(Abound bio/Saudivax)
Drug Alias NameIgG1 Ab1(University of Pittsburgh Medical Center/University of North Carolina/University of Texas Medical Branch at Galveston/Abound bio/Saudivax)human monoclonal antibodies (Aboundbio/SaudiVax)IgG1 Ab1 (Abound bio/Saudivax)human monoclonal antibodies (Aboundbio/SaudiVax)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMiddle EastUnited StatesASEAN +[5] 
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pittsburgh Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesSaudiVaxAbound Bio Inc
Inactive CompaniesUniversity Of Pittsburgh Medical Center
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A